TRANSCEND-T2D-2 topline data show retatrutide lowered A1C more and produced over twice the weight loss of semaglutide 2 mg in type 2 diabetes.
Opinion|Podcasts|October 26, 2023
Protecting Cardiorenal Function in Diabetic Kidney Disease
Listen
0:00 / 0:00
Experts discuss the intricate relationship between diabetes, kidney disease, and cardiovascular function and explore the evolving landscape of therapies with cardiorenal benefits.
Advertisement
1:27 Diabetes, kidney disease, and CV risk interrelationship
3:54 Expanding indications for SGLT2 inhibitors for CV risk reduction
5:40 CV benefits of SGLT2 inhibitors in clinical trials
7:20 Use of finerenone for CKD
9:20 Using stage and severity of CKD to guide treatment choice
14:00 Benefits of combining finerenone with SGLT2 inhibitors
16:30 Potential use of GLP 1 agonists for CKD
19:20 Considerations for incorporating therapies for CKD
23:00 Key takeaways on using new treatments for CKD
Advertisement
Related to this article
Tom Martens, MD, joins Diana Isaacs, PharmD, and Natalie Bellini, DNP, to discuss CONNECT trial data on CGM in non-insulin-treated type 2 diabetes.
Hiddo Heerspink, PharmD, PhD, joins Brendon Neuen, MBBS, PhD, and Shikha Wadhwani, MD, MS, to unpack finerenone’s FIND-CKD data in FSGS.
Lesley Inker, MD, MS, joins Brendon Neuen, MBBS, PhD, to unpack GFR slope and hierarchical composite endpoints in glomerular disease trials.
Suceena Alexander, MD, joins Brendon Neuen, MBBS, PhD, and Shikha Wadhwani, MD, MS, to discuss platform trial design in IgA nephropathy and beyond.
Approval of obinutuzumab for adults with PMN follows MAJESTY, where 37% vs 6% achieved complete remission at week 104 vs tacrolimus.
Stay updated with the latest healthcare breakthroughs, including 96-week durability data for GSK’s bepirovirsen in hepatitis B, and more.
In 757 adults with severe hypertriglyceridemia, plozasiran cut acute pancreatitis events by 78% overall and 91% in those with recent prior pancreatitis.
Advertisement
Advertisement
Trending on HCPLive
1
Q&A: Mucus Plugging, Multimorbidity, and GOLD 2027, With Gerard Criner, MD
2
ABCs in Dermatology: Rethinking Corticosteroid Stewardship in Chronic Hand Eczema
3
Omalizumab Linked to 0 Epinephrine Use in Alpha-Gal Syndrome
4
Early Dupilumab in Pediatric EoE Tied to Lower Incident Asthma
5